COMPANY PROFILE -Cipla Ltd.
Business Sector :Pharmaceuticals
Operating Geography :India, Asia, Global
About Cipla Ltd. :
Founded in 1935 by Dr. K.A. Hameid, Cipla Ltd. is a multinational pharmaceutical company headquartered in Mumbai, India. The company provides medicines for respiratory, cardiovascular disease, arthritis, diabetes, weight control, depression and other medical conditions. It also provides therapies for respiratory, asthma, pediatric asthma, COPD, nebulization, HIV/AIDs, and Oncology. Cipla has its presence in more than 80 countries including India, USA, Europe, Australia, Sri-Lanka, South Africa, and other emerging countries, and provides over 1,500 products across numerous therapeutic categories in more than 50 dosage forms. As of early 2021, the company has more than 25,000 employees across 46 state-of-the-art manufacturing facilities. Cipla’s product, Nicotex, won the gold at DIGIXX Awards 2021 and its digital campaign was recognized under “Best Use of Technology for Video Content”. As of March 2021, Cipla is the third largest pharma company in India and South Africa.
Cipla’s unique selling proposition or USP lies in using cutting edge technology and innovation to meet the demands of the patients. Cipla’s OneCiplaCredo reads, “We are a PURPOSE – INSPIRED, RESPONSIBILITY – CENTERED, INNOVATION – DRIVEN, EXCELLENCE - FOCUSED INTEGRITY & TRUST – ANCHORED, global pharmaceutical firm that consistently Cares for Life and delivers on its commitment to all our stakeholders – patients, regulators, customers, partners, employees, investors and community.”
Cipla Ltd. Revenue :
INR 19,160 crores - FY ending 31st March 2021
INR 17,132 crores - FY ending 31st March 2020
Competitive Analysis of Cipla Ltd.
The SWOT analysis for Cipla is presented below in a matrix followed by the detailed analysis report:
| Strengths | Weaknesses |
1. Reputed brand with strong product portfolio with leading share in respiratory and AVR’s category
2. Consistently strong financial performance and growth
3. Experienced management and promoters with established track record
4. Innovation through digitization and online platforms
5. Lung segment leadership across markets
6. Diversified manufacturing and operational presence
7. Strengthening position in South Africa and Emerging Markets
| 1. Coming with tag of Generics giant
2. Limited presence in developed countries
3. Dealings with negative spread (Campaign by AHF)
4. Regulatory risks and warnings from USFDA
|
| Opportunities | Threats |
1. Post pandemic global view and scope
2. Stretching footprint into developed countries
3. AI and digital analytics to play an increasing role in pharma
4. Unlocking of Respiratory franchise in the US
| 1. Constant evolution or changes in the drug pricing method in India by authorities
2. Strong competition at domestic level with limited market share
3. Dependence on China for raw materials
|
This is a custom report and will be delivered to your email inbox within 2 business days from purchase.
Detailed SWOT Analysis of Cipla Ltd.
Strength
1. Strong product portfolio with leading share in respiratory and AVR’s category: Cipla’s product portfolio consists mainly of generic products total about 1,500 products in 65 therapeutic categories and over 50 dosage forms. It has 46 manufacturing across 5 countries. Majority of the revenue contribution comes from India, USA, and South Africa. Cipla’s product portfolio spans various therapeutic areas including respiratory, anti-infectives, cardio-metabolic, urology, gastro-intestinal etc. The Company has been further strengthening the portfolio in therapies such as diabetology, women’s health, IVF and oncology. In FY2019-20 Cipla launched 54 new products across the world. Cipla holds 2nd position in world for inhaler sales by volume and 22% of the revenue comes from respiratory segment. Cipla known for bringing world’s first ever paradigm changing triple anti-retroviral therapy (Stavudine + Lamivudine + Nevirapine) in the treatment of HIV/AIDS in 2001. This breakthrough invention was made affordable and available to all at less than a ‘Dollar a Day’ brought down the treatment cost from $12,000 to $300 per year. Cipla also has its products into biosimilars and consumer healthcare category.
2. Consistently strong financial performance and growth: Cipla has major revenue share contribution from India, followed by Africa and North America. From past 5 years Cipla has showed positive growth revenue from INR 14,630 Cr to INR 19,160 Cr with CAGR of 7%. The EBIDTA has shown consistent increase from INR 2480 crore in FY15-16 to INR 4,303 crore in FY20-21 – recording 12% five-year CAGR. Profit After Tax (PAT) stood at INR 2,405 crore in FY20-21 recording 12% CAGR over the last five-year period. Strong free cash flows allowed Cipla to maintain a healthy net debt-to-equity, improving to -0.10 in FY20-21 from 0.05 in FY 2019-20. Above mentioned all financial data add as feathers to say that CIPLA is one of the strongest financially sustainable company.
The remaining section under "Strength" is available only in the 'Complete Report' on purchase.
Weakness
This section is available only in the 'Complete Report' on purchase.
Opportunity
This section is available only in the 'Complete Report' on purchase.
Threat
This section is available only in the 'Complete Report' on purchase.
The PESTLE analysis for Cipla is presented below in a table followed by the detailed analysis report.
| Political | Economical |
1. Government’s focus on improving ease of doing business and formulating policies to aid pharma industry
2. Geopolitical volatility increasing business risks
| Global medicine market is projected to grow at 3-6% annually |
| Social | Technological |
| 1. Building direct patient connect (B2C) with increasing digital adoption | 1. Digital transformation strategy to fuel business growth
2. Digital therapeutics – a segment with growing opportunity
3. Pharmacovigilance system to detect and assess any adverse effects
|
| Legal | Environmental |
1. Increasingly evolving global regulatory environment
2. Engagement with regulatory bodies and other stakeholders
3. Establishing robust Enterprise Risk Management (ERM) framework
| 1. Strong focus on Environment, Health & Safety (EHS) and Sustainability
2. Leveraging renewable energy and Agri-waste
|
This is a custom report and will be delivered to your email inbox within 2 business days from purchase.
Detailed Pestle Analysis of Cipla Ltd.
Political
1. Government’s focus on improving ease of doing business and formulating policies to aid pharma industry: The Union Minister of Chemicals & Fertilisers, D.V Sadananda Gowda claimed that the government of India is working towards reducing the regulatory compliance burden in order to improve ease of doing business of pharma industry in the country. During “The India Pharma 2021 & India Medical Device 2021”, the minister also forecasted that the industry has the ability to achieve USD 130 billion turnover by 2030. In support of improving ease of doing business and formulate policies, Cipla is also insisting the government to raise fund allocation for the healthcare sector. In its annual report 2018-19, Cipla’s Chairman Y K Hamied addressed that the healthcare sector of India is under constant pressure of population and disease, therefore it always require urgent attention.
The remaining section under "Political" is available only in the 'Complete Report' on purchase.
Economic
This section is available only in the 'Complete Report' on purchase.
Social
This section is available only in the 'Complete Report' on purchase.
Technological
This section is available only in the 'Complete Report' on purchase.
Legal
This section is available only in the 'Complete Report' on purchase.
Environmental
This section is available only in the 'Complete Report' on purchase.
Major Competitors :
- Sun Pharmaceutical Industries Ltd
- Dr. Reddy's Laboratories Ltd.
- Divi's Laboratories,
- Aurobindo Pharma,
- Torrent Pharmaceuticals,
- Lupin Ltd,
- Zydus Cadila Healthcare,
This is a custom report and will be delivered to your email inbox within 2 business days from purchase.
TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
You may also be interested in other analyses of Cipla Ltd.:
-
| Cipla Ltd. Porter's Five Forces Analysis |
|
-
-
| Cipla Ltd. Value Chain Analysis |
|
-
| Cipla Ltd. Covid-19 Impact Analysis |
|
-
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Company Overview Report
This report is shared in order to give you an idea of what the complete Company Overview Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Competitor Analysis Report
This report is shared in order to give you an idea of what the complete Competitor Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Porter's Five Forces Analysis Report
This report is shared in order to give you an idea of what the complete Porter's Five Forces Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
VRIO Analysis Report
This report is shared in order to give you an idea of what the complete VRIO Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Value Chain Analysis Report
This report is shared in order to give you an idea of what the complete Value Chain Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Regulatory Outlook Report
This report is shared in order to give you an idea of what the complete Regulatory Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Risk Analysis Report
This report is shared in order to give you an idea of what the complete Risk Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key Performance Indicators (KPI's) Report
This report is shared in order to give you an idea of what the complete Key Performance Indicators (KPI's) Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Environmental, Social, and Governance (ESG) Analysis Report
This report is shared in order to give you an idea of what the complete Environmental, Social, and Governance (ESG) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
M&A Analysis Report
This report is shared in order to give you an idea of what the complete M&A Report and Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Subsidiaries, Partnerships and Collaborations Report
This report is shared in order to give you an idea of what the complete Subsidiaries, Partnerships and Collaborations Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Stakeholder Analysis Report
This report is shared in order to give you an idea of what the complete Stakeholder Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Technology Landscape and Outlook Report
This report is shared in order to give you an idea of what the complete Technology Landscape and Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Covid-19 Impact Analysis Report
This report is shared in order to give you an idea of what the complete Covid-19 Impact Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key News and Events Report
This report is shared in order to give you an idea of what the complete Key News and Events Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
BCG Analysis Report
This report is shared in order to give you an idea of what the complete BCG Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Digital Marketing and Social Media Strategy Analysis Report
This report is shared in order to give you an idea of what the complete Digital Marketing and Social Media Strategy Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Segmentation, Targeting and Positioning (STP) Analysis Report
This report is shared in order to give you an idea of what the complete Segmentation, Targeting and Positioning (STP) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Ansoff Matrix Analysis Report
This report is shared in order to give you an idea of what the complete Ansoff Matrix Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Check Out Analysis of Other Relevant Companies
References used in Cipla Ltd. SWOT & PESTLE Analysis Report
1. Cipla Annual Report 2020-21 - https://www.cipla.com/sites/default/files/CIPLA-AR-2020-21-Single-Page.pdf
2. Cipla Annual Report 2019-20 - https://www.cipla.com/sites/default/files/2020-08/CIpla-AR-2019-20.pdf
3. Respiratory Therapies - Asthma | COPD | Nebulization – Cipla - https://www.cipla.com/our-offerings/our-therapies/respiratory
4. Cipla Limited February 24, 2021 Press Release - https://www.careratings.com/upload/CompanyFiles/PR/24022021061245_Cipla_Limited.pdf
5. Cipla Ltd. SWOT Analysis | Strength - https://www.moneycontrol.com/swot-analysis/cipla/C/
The detailed complete set of references are available on request in the 'Complete report' on purchase.
How to Reference This Page?
You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.
Cipla Ltd SWOT & PESTLE Analysis - SWOT & PESTLE.COM
SWOT & PESTLE.com (2021). Cipla Ltd SWOT & PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/cipla/ [Accessed 19 Oct, 2021].
In-text: (SWOT & PESTLE.com, 2021)
Copyrights and Disclaimer
Cipla Ltd. SWOT and PESTLE analysis has been conducted and reviewed by senior analysts from Barakaat Consulting.
Copyright of Cipla Ltd. SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.
Safe and secure payments
